The FDA announced on March 25, 2021, that Bard Peripheral Vascular Inc is recalling PowerPort duo M.R.I. Implantable Ports due to catheter flushing difficulties and septum dislodgements. The agency terminated the voluntary Class II recall.
How to tell if you have it
- Brand: Bard
- Product: PowerPort duo M.R.I. Implantable Port, with attachable 9.5F Polurethane Open-Ended Dual-Lumen Venous Catheter
- REF: 1829500
- UPC: 00801741027185
- Lot codes: REEU3063, REEV0989, REEV2633, REEX1380, REEZ1991
- Quantity: 2,194 units
The hazard
According to the FDA, the catheters may experience difficulty in flushing, infusion, and/or aspiration, and septum dislodgements.
Context
GovInfoNow's records show Bard Peripheral Vascular Inc has 40 other recalls on record since September 22, 2017. Other recent recalls of similar products include Bard Breast Biopsy System May Cause Procedure Interruptions (August 20, 2026), Bard Peripheral Vascular Recall: Broviac Cutdown Trays with SureCuff Cuff Risk of Sterile Barrier Compromise (December 12, 2025), and Bard Safe-T-Centesis 6 Fr Catheter Drainage Tray Recall: Erroneous Safety Indicator Risk (November 6, 2025). Other recent recalls of similar products include Stryker BARD Dynamic XT Deca Steerable Catheter Recall: Incomplete Seals Risk Infection (April 10, 2026), Bard PowerMidline Catheter Recall: Lidocaine Ampoules Deficient Manufacturing (May 21, 2026), and Stryker BARD Dynamic Tip Steerable Catheter Recall: Incomplete Sterile Seals (April 10, 2026).